Cel-Sci
CVM • AMEX
Cel-Sci is a biotechnology company in the healthcare sector trading on AMEX, led by CEO Geert R. Kersten, with a market cap of $27.1M.
CEOGeert R. Kersten
Next Earnings
Upcoming earnings announcement for Cel-Sci
Date
Thursday, May 14, 2026 (in a month)
Timing
Before Market Open (9:00 AM New York)
Fiscal Period
Q2 2026
Earnings History
Past 12 earnings reports for Cel-Sci
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 18, 2026 | Q1 2026 | -$0.68 | — | - | — |  10-Q |
| Dec 29, 2025 | Q4 2025 | $0.07 | — | - | — | 10-K |
| Aug 14, 2025 | Q3 2025 | -$1.36 | — | - | — | 10-Q |
| May 15, 2025 | Q2 2025 | -$0.08 | — | - | — | 10-Q |
| Feb 14, 2025 | Q1 2025 | -$0.11 | — | - | — | 10-Q |
| Jan 13, 2025 | Q4 2024 | -$0.09Est: -$0.11 | +18.2% | - | — | 10-K |
| Aug 15, 2024 | Q3 2024 | -$0.14Est: -$0.13 | -7.7% | - | — | 10-Q |
| May 16, 2024 | Q2 2024 | -$0.14 | — | - | — | 10-Q |
| Feb 14, 2024 | Q1 2024 | -$0.14 | — | - | — | 10-Q |
| Dec 21, 2023 | Q4 2023 | -$0.16 | — | - | — | — |
| Aug 11, 2023 | Q3 2023 | -$0.19Est: -$0.16 | -18.8% | - | — | 10-Q |
| May 12, 2023 | Q2 2023 | -$0.19 | — | - | — | — |